Almost normal cognitive function in patients during therapy for childhood acute lymphoblastic leukemia without cranial irradiation according to ALL-BFM 95 and COALL 06-97 protocols: Results of an Austrian-German multicenter longitudinal study and implications for follow-up

Paul Krappmann; Marios Paulides; Wolfgang Stöhr; Edith Ittner; Bernhard Plattig; Petra Nickel; Herwig Lackner; Martin Schrappe; Gritta Janka; Jörn D. Beck; Thorsten Langer

doi:10.1080/08880010601123281

Almost normal cognitive function in patients during therapy for childhood acute lymphoblastic leukemia without cranial irradiation according to ALL-BFM 95 and COALL 06-97 protocols: Results of an Austrian-German multicenter longitudinal study and implications for follow-up

Paul Krappmann, Marios Paulides, Wolfgang Stöhr, Edith Ittner, Bernhard Plattig, Petra Nickel, Herwig Lackner, Martin Schrappe, Gritta Janka, Jörn D. Beck, Thorsten Langer^*

^*Korrespondierende/r Autor/-in für diese Arbeit

Klinik für Kinder- und Jugendmedizin

24 Zitate (Scopus)

Abstract

In a multicenter study the authors prospectively investigated neurocognitive function in childhood ALL patients. Sixty-six patients (mean age at diagnosis 7.9 ± 3.6 years, 34 female), treated with repeated intrathecal and systemical methotrexate administrations without cranial irradiation, underwent psychometric testing for intelligence, concentration, and visual-motor integration postdiagnosis and after reinduction therapy. Although there was a statistically significant decline of intellectual function after reinduction therapy for younger patients and girls (IQ scores still within normative data range), there were no differences in visual-motor performance and concentration over the time of induction therapy. Thus, neurocognitive examination should focus on younger ALL patients and girls.

Originalsprache	Englisch
Zeitschrift	Pediatric Hematology and Oncology
Jahrgang	24
Ausgabenummer	2
Seiten (von - bis)	101-109
Seitenumfang	9
ISSN	0888-0018
DOIs	https://doi.org/10.1080/08880010601123281
Publikationsstatus	Veröffentlicht - 02.2007

Fördermittel

Received 21 March 2006; accepted 13 November 2006. Paul Krappmann and Marios Paulides contributed equally to this paper. The investigation was supported by the Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsförderung (ELAN) and the Deutsche Leukämie Forschungshilfe. We wish to thank the participating centers. Address correspondence to PD Dr. med. Th. Langer, Abteilung für Immunologie und Onkologie, Universitäts-Kinder-und Jugendklinik, Loschgestraße 15, 91054 Erlangen, Germany. E-mail: less@ kinder.imed.uni-erlangen.de

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

SDG 3 – Gesundheit und Wohlergehen

Strategische Forschungsbereiche und Zentren

Forschungsschwerpunkt: Gehirn, Hormone, Verhalten - Center for Brain, Behavior and Metabolism (CBBM)

Dokumente

10.1080/08880010601123281

Weitere Links

Link to publication in Scopus

Fingerprint

Untersuchen Sie die Forschungsthemen von „Almost normal cognitive function in patients during therapy for childhood acute lymphoblastic leukemia without cranial irradiation according to ALL-BFM 95 and COALL 06-97 protocols: Results of an Austrian-German multicenter longitudinal study and implications for follow-up“. Zusammen bilden sie einen einzigartigen Fingerprint.

Zitieren

Krappmann, P., Paulides, M., Stöhr, W., Ittner, E., Plattig, B., Nickel, P., Lackner, H., Schrappe, M., Janka, G., Beck, J. D., & Langer, T. (2007). Almost normal cognitive function in patients during therapy for childhood acute lymphoblastic leukemia without cranial irradiation according to ALL-BFM 95 and COALL 06-97 protocols: Results of an Austrian-German multicenter longitudinal study and implications for follow-up. Pediatric Hematology and Oncology, 24(2), 101-109. https://doi.org/10.1080/08880010601123281

Krappmann, Paul ; Paulides, Marios ; Stöhr, Wolfgang et al. / Almost normal cognitive function in patients during therapy for childhood acute lymphoblastic leukemia without cranial irradiation according to ALL-BFM 95 and COALL 06-97 protocols: Results of an Austrian-German multicenter longitudinal study and implications for follow-up. in: Pediatric Hematology and Oncology. 2007 ; Jahrgang 24, Nr. 2. S. 101-109.

@article{26cda6045018410cb8884caeb54a4aaf,

title = "Almost normal cognitive function in patients during therapy for childhood acute lymphoblastic leukemia without cranial irradiation according to ALL-BFM 95 and COALL 06-97 protocols: Results of an Austrian-German multicenter longitudinal study and implications for follow-up",

abstract = "In a multicenter study the authors prospectively investigated neurocognitive function in childhood ALL patients. Sixty-six patients (mean age at diagnosis 7.9 ± 3.6 years, 34 female), treated with repeated intrathecal and systemical methotrexate administrations without cranial irradiation, underwent psychometric testing for intelligence, concentration, and visual-motor integration postdiagnosis and after reinduction therapy. Although there was a statistically significant decline of intellectual function after reinduction therapy for younger patients and girls (IQ scores still within normative data range), there were no differences in visual-motor performance and concentration over the time of induction therapy. Thus, neurocognitive examination should focus on younger ALL patients and girls.",

author = "Paul Krappmann and Marios Paulides and Wolfgang St{\"o}hr and Edith Ittner and Bernhard Plattig and Petra Nickel and Herwig Lackner and Martin Schrappe and Gritta Janka and Beck, \{J{\"o}rn D.\} and Thorsten Langer",

note = "Funding Information: Received 21 March 2006; accepted 13 November 2006. Paul Krappmann and Marios Paulides contributed equally to this paper. The investigation was supported by the Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsf{\"o}rderung (ELAN) and the Deutsche Leuk{\"a}mie Forschungshilfe. We wish to thank the participating centers. Address correspondence to PD Dr. med. Th. Langer, Abteilung f{\"u}r Immunologie und Onkologie, Universit{\"a}ts-Kinder-und Jugendklinik, Loschgestra{\ss}e 15, 91054 Erlangen, Germany. E-mail: less@ kinder.imed.uni-erlangen.de Copyright: Copyright 2018 Elsevier B.V., All rights reserved.",

year = "2007",

month = feb,

doi = "10.1080/08880010601123281",

language = "English",

volume = "24",

pages = "101--109",

journal = "Pediatric Hematology and Oncology",

issn = "0888-0018",

publisher = "Taylor and Francis Ltd.",

number = "2",

}

Krappmann, P, Paulides, M, Stöhr, W, Ittner, E, Plattig, B, Nickel, P, Lackner, H, Schrappe, M, Janka, G, Beck, JD & Langer, T 2007, 'Almost normal cognitive function in patients during therapy for childhood acute lymphoblastic leukemia without cranial irradiation according to ALL-BFM 95 and COALL 06-97 protocols: Results of an Austrian-German multicenter longitudinal study and implications for follow-up', Pediatric Hematology and Oncology, Jg. 24, Nr. 2, S. 101-109. https://doi.org/10.1080/08880010601123281

Almost normal cognitive function in patients during therapy for childhood acute lymphoblastic leukemia without cranial irradiation according to ALL-BFM 95 and COALL 06-97 protocols: Results of an Austrian-German multicenter longitudinal study and implications for follow-up. / Krappmann, Paul; Paulides, Marios; Stöhr, Wolfgang et al.
in: Pediatric Hematology and Oncology, Jahrgang 24, Nr. 2, 02.2007, S. 101-109.

Publikation: Beiträge in Fachzeitschriften › Zeitschriftenaufsätze › Forschung › Begutachtung

TY - JOUR

T1 - Almost normal cognitive function in patients during therapy for childhood acute lymphoblastic leukemia without cranial irradiation according to ALL-BFM 95 and COALL 06-97 protocols: Results of an Austrian-German multicenter longitudinal study and implications for follow-up

AU - Krappmann, Paul

AU - Paulides, Marios

AU - Stöhr, Wolfgang

AU - Ittner, Edith

AU - Plattig, Bernhard

AU - Nickel, Petra

AU - Lackner, Herwig

AU - Schrappe, Martin

AU - Janka, Gritta

AU - Beck, Jörn D.

AU - Langer, Thorsten

N1 - Funding Information: Received 21 March 2006; accepted 13 November 2006. Paul Krappmann and Marios Paulides contributed equally to this paper. The investigation was supported by the Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsförderung (ELAN) and the Deutsche Leukämie Forschungshilfe. We wish to thank the participating centers. Address correspondence to PD Dr. med. Th. Langer, Abteilung für Immunologie und Onkologie, Universitäts-Kinder-und Jugendklinik, Loschgestraße 15, 91054 Erlangen, Germany. E-mail: less@ kinder.imed.uni-erlangen.de Copyright: Copyright 2018 Elsevier B.V., All rights reserved.

PY - 2007/2

Y1 - 2007/2

N2 - In a multicenter study the authors prospectively investigated neurocognitive function in childhood ALL patients. Sixty-six patients (mean age at diagnosis 7.9 ± 3.6 years, 34 female), treated with repeated intrathecal and systemical methotrexate administrations without cranial irradiation, underwent psychometric testing for intelligence, concentration, and visual-motor integration postdiagnosis and after reinduction therapy. Although there was a statistically significant decline of intellectual function after reinduction therapy for younger patients and girls (IQ scores still within normative data range), there were no differences in visual-motor performance and concentration over the time of induction therapy. Thus, neurocognitive examination should focus on younger ALL patients and girls.

AB - In a multicenter study the authors prospectively investigated neurocognitive function in childhood ALL patients. Sixty-six patients (mean age at diagnosis 7.9 ± 3.6 years, 34 female), treated with repeated intrathecal and systemical methotrexate administrations without cranial irradiation, underwent psychometric testing for intelligence, concentration, and visual-motor integration postdiagnosis and after reinduction therapy. Although there was a statistically significant decline of intellectual function after reinduction therapy for younger patients and girls (IQ scores still within normative data range), there were no differences in visual-motor performance and concentration over the time of induction therapy. Thus, neurocognitive examination should focus on younger ALL patients and girls.

UR - https://www.scopus.com/pages/publications/34247158203

U2 - 10.1080/08880010601123281

DO - 10.1080/08880010601123281

M3 - Journal articles

C2 - 17454775

AN - SCOPUS:34247158203

SN - 0888-0018

VL - 24

SP - 101

EP - 109

JO - Pediatric Hematology and Oncology

JF - Pediatric Hematology and Oncology

IS - 2

ER -

Krappmann P, Paulides M, Stöhr W, Ittner E, Plattig B, Nickel P et al. Almost normal cognitive function in patients during therapy for childhood acute lymphoblastic leukemia without cranial irradiation according to ALL-BFM 95 and COALL 06-97 protocols: Results of an Austrian-German multicenter longitudinal study and implications for follow-up. Pediatric Hematology and Oncology. 2007 Feb;24(2):101-109. doi: 10.1080/08880010601123281